Rapid opiate detoxification treatments

Drug and Alcohol Review

Volumn 18, Issue 1, 1999, Pages 75-81

  Bearn, Jennifer ^a,b   Gossop, Michael ^a   Strang, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BETHLEM ROYAL HOSPITAL   (United Kingdom)

Author keywords

Anaesthesia; Detoxification; Naloxone; Naltrexone; Opiate; Sedation

Indexed keywords

EID: 0033463924     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595239996789     Document Type: Review

References (40)

1. Kleber H. Detoxification from narcotics. In: Lowinson J, Ruiz P, eds. Substance abuse. Baltimore: Williams and Wilkins, 1981.
2. Farrell M. Opiate withdrawal. Addiction 1994;89: 1471-5.
3. Mattick RP, Hall W. Are detoxification programmes effective? Lancet 1996;347:97-100.
4. Gossop M, Battersby M, Strang J. Self-detoxification by opiate addicts: a preliminary investigation. B J Psychiatr 1991;159:208-12.
5. Gossop M. The detoxification of high dose heroin addicts in Pakistan. Drug Alcohol Depend 1989;24: 143-50.
6. Loimer N, Schmid R, Presslich O, Lenz K. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. J Psychiatr Res 1989;23:81-6.
7. Loimer N, Lenz K, Schmid R, Presslich O. Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. Am J Psychiatr 1991;148:933-5.
8. Legarda JJ, Gossop M. A 24 hour inpatient detoxification treatment for heroin addicts: a preliminary investigation. Drug Alcohol Depend 1994;35:91-3.
9. Brewer C. Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation. Addict Biol 1997;2:291-302.
10. Strang J, Bearn J, Gossop M. Opiate detoxification under anaesthesia. Br Med J 1997;315:1249-50.
11. Aghajanian GK. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal responses by clonidine. Nature 1978;276:186-8.
12. Aghajanian GK, Wang YY. Common alpha-2 and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices. Neuropharmacology 1987;26:789-800.
13. Nestler EJ. Under siege: the brain on opiates. Neuron 1996;16:897-900.
14. Taylor JR, Elsworth JD, Garcia EJ, Grant SJ, Roth RH, Redmond Jr DE. Clonidine infusions into the locus coeruleus attenuate behavioural and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology 1990;96:121-34.
15. Rasmussen K, Beitner-Johnson D, Krystal JH, Aghajanian GK, Nestler EJ. Opiate withdrawal and the rat locus coeruleus: behavioural, elcctrophysiological and biochemical correlates. J Neurosci 1990;10: 2308-17.
16. Blachly P, Casey D, Marcel L, Denney D. Rapid detoxification from heroin and methadone using naloxone. A model for the study of the treatment of the opiate abstinence syndrome. In: Senay E, Shorty V, Alkesne M, eds. Developments in the field of drug abuse. Cambridge, MA: Schenkma Publishing Co., 1975:327-36.
17. Resnick RB, Kestenbaum RS, Washton A, Poole D. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone. Clin Pharmacol Ther 1977; 21:409-13.
18. Resnick RB, Kestenbaum RS, Gaztanaga P, Volanka J, Freedman AM. Experimental techniques for rapid withdrawal from methadone maintenance: results of pilot trials. In: Senay E, Shorty V, Alkesne M, eds. Developments in the field of drug abuse. Cambridge, MA: Schenkma Publishing Co., 1975:321-6.
19. Riordan CE, Kleber HD. Rapid opiate detoxification with clonidine and naloxone. Lancet 1980;1: 1079-80.
20. Charney DS, Heninger GR, Kleber HD. The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone. Am J Psychiatr 1986;143:831-7.
21. Vining E, Kosten TR, Kleber HD. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict 1988;83:567-75.
22. Hendrie CA. Marked attenuation of behavioural and nocioreceptive responses to morphine withdrawal by the opiate antagonist naloxone. Pharmacol Biochem Behav 1988;23:863-70.
23. Vlissides DN, Jenner FA, Liappas IA. The use of naloxone during the withdrawal syndrome from heroin. Br J Psychiatr 1988;152:565-7.
24. Merrill J, Marshall R. Opioid detoxification using naloxone. Drug Alcohol Rev 1997;16:3-6.
25. Cruz SL, Villarreal JE, Volkow ND. Further evidence that naloxone acts as an inverse opiate agonist: implication for drug dependence and withdrawal. Life Sci 1996 58:381-9.
26. Simon DL. Rapid opioid detoxification using opioid antagonists: history, theory and the state of the art. J Addict Dis 1997;16:103-21.
27. Brewer C, Rezae H, Bailey C. Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique. Br J Psychiatr 1988;153:340-3.
28. Bartter T, Gooberman LL. Rapid opiate detoxification. Am J Drug Alcohol Abuse 1996;22:489-95.
29. Loimer N, Hofmann P, Chaudry H. Short non-invasive opiate detoxification. Am J Psychiatr 1993; 150:839.
30. Loimer N, Schmid R, Lenz K, Presslich O, Grunberger J. Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone. Br J Psychiatr 1990;157:748-52.
31. Loimer N, Linzmayer L, Schmid R, Grunberger J. Similar efficacy of abrupt and gradual opiate detoxification. Am J Drug Alcohol Abuse 1991;17: 307-12.
32. Gossop M, Griffiths P, Bradley B, Strang J. Opiate withdrawal symptoms response to a 10 day and 21 day methadone withdrawal programme. Br J Psychiatr 1989;154:360-3.
33. Gerstein DR, Harwood HJ. Treating drug problems, vol. 1. A study of effectiveness and financing of public and private drug treatment systems. Washington DC: Institute of Medicine, National Academy Press, 1990.
34. Gerra G, Marcato A, Caccavari R, Fontanesi B, Delsignore R, Fertonani G, Avanzini P, Rustichelli P, Passeri M. Clonidine and opiate receptor antagonists in the treatment of heroin addiction. J Subst Abuse Treat 1995;12:35-41.
35. Seoane A, Carrasco G, Cabre L, Puiggros A, Hernandez E, Alvarez M, Costa J, Molina R, Sobrepere G. Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatr 1997;171:340-5.
36. Utting JE. Major catastrophes in anaesthesia. In: Nunn JF, Utting JE, Brown BR, eds. General anaesthesia. London: Butterworths 1989;675-81.
37. Mayor S. Specialists criticise treatment for heroin addiction. Br Med J 1997;314:1365.
38. Tortella FC. Endogenous opioid peptides and epilepsy: quieting the seizing brain. Trends Pharmacol Sci 1988;9:366-72.
39. Bartenstein PA, Duncan JS, Prevett MC, Cunningham VJ, Fish DR, Jones AKP, Luthra SK, Sawle GV, Brooks DJ. Investigation of the opioid system in absence seizures with positron emission tomography. J Neurol Neurosurg Psychiatr 1993;56:1295-302.
40. Self DW, Nestler EJ. Molecular mechanisms of drug reinforcement and addition. Ann Rev Neurosci 1995; 18:463-95.